市場調查報告書
商品編碼
1056665

全球細胞增殖試劑盒市場:COVID-19 的增長、趨勢、影響、預測(2022-2027 年)

Cell Proliferation Kit Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

出版日期: | 出版商: Mordor Intelligence Pvt Ltd | 英文 121 Pages | 商品交期: 2-3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

全球細胞增殖試劑盒 (CPK) 市場預計在預測期內將以 7.5% 的複合年增長率增長。

市場增長的主要驅動力是越來越多的被診斷患有癌症和腫瘤的患者,以及全球範圍內正在進行的研發活動。這些疾病的患病率增加為有效治療提供了對活細胞計數和代謝活動的早期評估,並正在推動市場增長。此外,政府加大力度抑制醫療費用負擔,以及提高醫療保健意識,預計將提振市場。

本報告調查了全球細胞增殖試劑盒 (CPK) 市場,並提供了市場概況、分析類型、方法、最終用戶和地區的趨勢,以及進入市場的公司概況。

目錄

第一章介紹

第二章調查方法

第 3 章執行摘要

第四章市場動態

  • 市場概況
  • 市場促進因素
    • 基於細胞的方法學技術進步的興起
    • 慢性病和生活方式相關疾病的患病率增加
    • 增加在藥物篩選中的應用
  • 市場製約因素
    • 缺乏熟練操作這些技術的人員
    • 高維護和運營成本
    • 小細胞樣本的結果不敏感
  • 波特五力分析

第 5 章市場細分

  • 按檢測類型
    • DNA合成細胞增殖試驗
    • 代謝活性細胞增殖試驗
    • 抗原細胞增殖試驗
  • 按方法
    • 比色法
    • 螢光發射
    • 其他
  • 最終用戶
    • 製藥和生物技術公司
    • 學術/研究所
    • 其他
  • 按地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東/非洲
    • 南美洲

第6章競爭態勢

  • 公司簡介
    • Thermo Fisher Scientific Inc
    • Merck KGaA
    • Bio-Rad Laboratories Inc
    • Becton, Dickinson and Company
    • Agilent Technologies Inc (BioTek Instruments Inc)
    • GE Healthcare
    • Perkin Elmer Inc
    • Biological Industry
    • Biotium
    • Mindray Medical International Limited

第7章 市場機會與未來動向

目錄
Product Code: 68522

The Cell Proliferation Kit (CPK) Market is expected to register a CAGR of 7.5% during the forecast period. The major factors attributing to the growth of the market are rising volume of patients diagnosed with cancer, tumors and ongoing R&D activities across the globe. As per World health Organization report, cancer is a leading cause of death worldwide and estimated that nearly 9.6 million deaths in 2018. Also, lung cancer was identified as the most common cancer leading to death with 1.76 million deaths in 2018. Thus, growing prevalence of these diseases resulted in earlier assessment of viable cell-count, metabolic activity for effective treatment fuels the market growth. Furthermore, rise in government initiatives to control the healthcare burden, and growing healthcare awareness among are likely boost the Cell Proliferation Kit market.

Key Market Trends

Colorimetry Sub-segment is Expected to Hold a Major Market Share in the Cell Proliferation Kit Market

Colorimetry holds a significant market share in Cell Proliferation Kit market over the forecast period. The dominance is owing to increased adoption as measuring markers of cell activity. Huge demand for the method is due to their cost effectiveness, easier retrieval of high-throughput data, and key role in assessment of therapeutic efficacy. This method is widely employed determining various cellular activity such as DNA synthesis, metabolic activity, ATP production, the number of cells present etc., Various types of colorimetric assays like WST-1, WST-8, XTT, MTT, and others are available specific to tests. Thus, above mentioned factors are expected to fuel the growth of the segment.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to hold a major market share in the cell proliferation kit market. The dominance is due to growing number of new cancer cases like melanoma, urothelial carcinoma, lung cancer, and others each year in the region. Also, the presence of huge population of baby boomers leads to huge volume of elderly people who are at the risk of cancers. According to the estimates published by the American Cancer Society for the year 2020, lung cancer is the second most common cancer leading to 135,720 deaths in both men and women. Also, as per Thyroid Cancer Survivors Association, thyroid cancer affects nearly 52,890 new cases in the United States in 2020, which increased from 52,070 cases in the year 2019. Thus, growing cancer cases leads to increased demand for determining the growth rate of cellular population driving the growth of the market. Furthermore, ongoing research activities in oncology by key pharma and biotech companies necessitates the use of these kits to determine the therapeutic efficiency of drugs. Therefore, due to above mentioned factors expected to boost the cell proliferation kit market in the region to a large extent during the forecast period.

Competitive Landscape

The cell proliferation kit market is moderately competitive and consists of a several major players. In terms of market share, few of the major players are currently dominating the market. Some of the companies which are currently dominating the market are Merck KGaA, Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, Becton, Dickinson and Company, and Agilent Technologies Inc (BioTek Instruments Inc).

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rise in Technological Advancements in Cell-based Methodologies
    • 4.2.2 Rising Prevalence of Chronic Diseases and Lifestyle Disorders
    • 4.2.3 Increasing Application in Drug Screening
  • 4.3 Market Restraints
    • 4.3.1 Lack of Skilled Personnel to Operate these Technologies
    • 4.3.2 High Maintenance and Operational Costs
    • 4.3.3 Lesser Sensitive Results with Smaller Samples of Cells
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 Assay Type
    • 5.1.1 DNA Synthesis Cell Proliferation Assay
    • 5.1.2 Metabolic Activity Cell Proliferation Assay
    • 5.1.3 Antigen Associated Cell Proliferation Assay
  • 5.2 Method
    • 5.2.1 Colorimetry
    • 5.2.2 Fluorescence
    • 5.2.3 Others
  • 5.3 End-user
    • 5.3.1 Pharma & Biotech Companies
    • 5.3.2 Academic & Research Institutes
    • 5.3.3 Others
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Thermo Fisher Scientific Inc
    • 6.1.2 Merck KGaA
    • 6.1.3 Bio-Rad Laboratories Inc
    • 6.1.4 Becton, Dickinson and Company
    • 6.1.5 Agilent Technologies Inc (BioTek Instruments Inc)
    • 6.1.6 GE Healthcare
    • 6.1.7 Perkin Elmer Inc
    • 6.1.8 Biological Industry
    • 6.1.9 Biotium
    • 6.1.10 Mindray Medical International Limited

7 MARKET OPPORTUNITIES AND FUTURE TRENDS